Nora V. Bergasa. 2022. Clinical Cases in Hepatology. Clinical Cases in Hepatology
123
162
.
Ahmad Hassan Ali, Brian D. Juran, Erik M. Schlicht, Jackie K. Bianchi, Bryan M. McCauley, Elizabeth J. Atkinson & Konstantinos N. Lazaridis. (2021) The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis. BMC Gastroenterology 21:1.
Crossref
Narendra S. Choudhary, Sanjiv Saigal, Srikanth Thummala, Neeraj Saraf, Amit Rastogi, Prashant Bhangui, Thiagrajan Srinivasan, Sanjay K. Yadav, Samiran Nundy & Arvinder S. Soin. (2020) Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation. Journal of Clinical and Experimental Hepatology 10:5, pages 442-447.
Crossref
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo & Sergio Iván Hoyos-Duque. (2020) Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 33:3, pages 251-261.
Crossref
Mohammad Reza Fattahi, Seyyed Ali Malek-Hosseini, Gholam Reza Sivandzadeh, Ali Reza Safarpour, Kamran Bagheri Lankarani, Ali Reza Taghavi & Fardad Ejtehadi. (2017) Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases 23:7, pages 1160-1167.
Crossref
Roger W. Chapman & Kate D. Williamson. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
531
547
.
Aditi KumarDaniel WheatleyAmar Puttanna. (2016) Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management. Clinical Medicine Insights: Gastroenterology 9, pages CGast.S38451.
Crossref
J. Camilo Barreto & J. Michael Millis. 2016. Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Hepatobiliary and Pancreatic Surgery
321
327
.
James H. Tabibian, Steven P. O'Hara, Christy E. Trussoni, Pamela S. Tietz, Patrick L. Splinter, Taofic Mounajjed, Lee R. Hagey & Nicholas F. LaRusso. (2015) Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis. Hepatology 63:1, pages 185-196.
Crossref
Vinay Sundaram, Gina Choi, Christie Y. Jeon, Walid S. Ayoub, Nicholas N. Nissen, Andrew S. Klein & Tram T. Tran. (2015) Donation After Cardiac Death Liver Transplantation in Primary Sclerosing Cholangitis. Transplantation 99:5, pages 973-978.
Crossref
H. Yanai, S. Matalon, A. Rosenblatt, H. Awadie, T. Berdichevski, Y. Snir, U. Kopylov, L. Katz, A. Stein, L. Mlynarsky, H. Tulchinsky, F. M. Konikoff, S. Ben Horin, M. Braun, Z. Ben-Ari, Y. Chowers, Y. Baruch, O. Shibolet & I. Dotan. (2014) Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease. Journal of Crohn's and Colitis 9:2, pages 177-184.
Crossref
Ahmad H Ali, Elizabeth J Carey & Keith D Lindor. (2015) Current research on the treatment of primary sclerosing cholangitis. Intractable & Rare Diseases Research 4:1, pages 1-6.
Crossref
Aksana Höblinger, Sven Jonas, Gereon Gäbelein & Tillmann Sauerbruch. 2015. Viszeralmedizin. Viszeralmedizin
351
363
.
Johannes Klose, Michelle A. Klose, Courtney Metz, Frank Lehner, Michael P. Manns, Juergen Klempnauer, Nils Hoppe, Harald Schrem & Alexander Kaltenborn. (2014) Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbeck's Archives of Surgery 399:8, pages 1021-1029.
Crossref
Ijeoma A. Azodo, Rowan W. Parks & O. James Garden. 2014. Biliary Tract and Gallbladder Cancer. Biliary Tract and Gallbladder Cancer
1
31
.
Swastik Agrawal & Radha K. Dhiman. (2013) Hepatobiliary Quiz-6 (2013). Journal of Clinical and Experimental Hepatology 3:2, pages 171-176.
Crossref
Andres F. Carrion & Kalyan Ram Bhamidimarri. (2013) Liver Transplant for Cholestatic Liver Diseases. Clinics in Liver Disease 17:2, pages 345-359.
Crossref
Ashwani K. Singal & Patrick S. Kamath. (2013) Model for End-stage Liver Disease. Journal of Clinical and Experimental Hepatology 3:1, pages 50-60.
Crossref
Kristin Kaasen Jrgensen, Krzysztof Grzyb, Knut E.A. Lundin, Ole Petter F. Clausen, Geir Aamodt, Erik Schrumpf, Morten H. Vatn & Kirsten Muri Boberg. (2012) Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflammatory Bowel Diseases 18:3, pages 536-545.
Crossref
. 2012. Klinische Immunologie. Klinische Immunologie
e1
e80
.
John Halliday & Roger W. Chapman. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
579
600
.
David R. Lichtenstein. (2011) Hepatobiliary Complications of Inflammatory Bowel Disease. Current Gastroenterology Reports 13:5, pages 495-505.
Crossref
Kellie L. Mathis, Luis A. Benavente-Chenhalls, Eric J. Dozois, Bruce G. Wolff & David W. Larson. (2011) Short- and Long-Term Surgical Outcomes in Patients Undergoing Proctocolectomy With Ileal Pouch-Anal Anastomosis in the Setting of Primary Sclerosing Cholangitis. Diseases of the Colon & Rectum 54:7, pages 787-792.
Crossref
E. L. Culver & R. W. Chapman. (2011) Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 33:12, pages 1273-1291.
Crossref
Marco Carbone & James Neuberger. (2011) Liver transplantation in PBC and PSC: Indications and disease recurrence. Clinics and Research in Hepatology and Gastroenterology 35:6-7, pages 446-454.
Crossref
Simon Rushbrook & Roger W. Chapman. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
342
352
.
Murad Aljiffry, Paul D. Renfrew, Mark J. Walsh, Marie Laryea & Michele Molinari. (2011) Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB 13:2, pages 79-90.
Crossref
Holger H Lutz & Jens JW Tischendorf. (2011) Management of primary sclerosing cholangitis. World Journal of Hepatology 3:6, pages 137.
Crossref
Sue Cullen & Roger Chapman. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
528
552
.
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider & Gregory J. Gores. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:2, pages 660-678.
Crossref
Jens J. W. Tischendorf, Andreas Geier & Christian Trautwein. (2008) Current diagnosis and management of primary sclerosing cholangitis. Liver Transplantation 14:6, pages 735-746.
Crossref
Karouk Said, Hans Glaumann & Annika Bergquist. (2008) Gallbladder disease in patients with primary sclerosing cholangitis. Journal of Hepatology 48:4, pages 598-605.
Crossref
Johannes Roksund Hov, Kirsten Muri Boberg & Tom H Karlsen. (2008) Autoantibodies in primary sclerosing cholangitis. World Journal of Gastroenterology 14:24, pages 3781.
Crossref
Richard B. FreemanJr.Jr.. (2007) The Model for End-stage Liver Disease Comes of Age. Clinics in Liver Disease 11:2, pages 249-263.
Crossref
T H Karlsen, K M Boberg, M Vatn, A Bergquist, J Hampe, E Schrumpf, E Thorsby, S Schreiber & B A Lie. (2007) Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes & Immunity 8:3, pages 275-278.
Crossref
Irma Matinlauri, Markku Nurminen, Krister Höckerstedt & Helena Isoniemi. (2007) Human leukocyte antigen associations in Finnish liver transplantations due to primary sclerosing cholangitis and primary biliary cirrhosis. Open Medicine 2:1, pages 12-25.
Crossref
T. H. Karlsen, K. M. Boberg & E. Schrumpf. 2007. Bile Acids: Biological Actions and Clinical Relevance. Bile Acids: Biological Actions and Clinical Relevance
226
237
.
Joy Worthington & Roger Chapman. (2006) Primary sclerosing cholangitis. Orphanet Journal of Rare Diseases 1:1.
Crossref
Gregory J. Gores, Robert G. Gish, Roshan Shrestha & Russell H. Wiesner. (2006) Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver Transplantation 12:S3, pages S91-S92.
Crossref
Tom H. Karlsen, Benedicte A. Lie, Kathrine Frey Frøslie, Erik Thorsby, Ulrika Broomé, Erik Schrumpf & Kirsten M. Boberg. (2006) Polymorphisms in the Steroid and Xenobiotic Receptor Gene Influence Survival in Primary Sclerosing Cholangitis. Gastroenterology 131:3, pages 781-787.
Crossref
Phunchai Charatcharoenwitthaya & Keith D. Lindor. (2006) Primary sclerosing cholangitis: Diagnosis and management. Current Gastroenterology Reports 8:1, pages 75-82.
Crossref
Ingmar Königsrainer, Ruth Ladurner, Claudia Schulz, Wolfgang Steurer & Alfred Königsrainer. 2006. Inflammatory Bowel Disease and Familial Adenomatous Polyposis. Inflammatory Bowel Disease and Familial Adenomatous Polyposis
317
320
.
Bjorn Brandsaeter, Erik Schrumpf, Oystein Bentdal, Kurt Brabrand, Hans Jorgen Smith, Andreas Abildgaard, Ole Petter Clausen & Kristian Bjoro. (2005) Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors. Liver Transplantation 11:11, pages 1361-1369.
Crossref
L. Gheorghe, I. Popescu, R. Iacob, S. Iacob & C. Gheorghe. (2005) Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transplant International 18:5, pages 572-576.
Crossref
George R MacFaul & Roger W Chapman. (2005) Sclerosing cholangitis. Current Opinion in Gastroenterology 21:3, pages 348-353.
Crossref
C. P. Strassburg, T. Becker, J. Klempnauer & M. P. Manns. (2004) Lebertransplantation zwischen Indikation und SpenderallokationLiver transplantation: Challenge of medical necessity and allocation. Der Internist 45:11, pages 1233-1245.
Crossref
Kristian Bjøro & Erik Schrumpf. (2004) Liver transplantation for primary sclerosing cholangitis. Journal of Hepatology 40:4, pages 570-577.
Crossref